Nanjing Well Pharmaceutical Co Ltd (603351) — Strategic Asset Allocation Index
Nanjing Well Pharmaceutical Co Ltd (603351) has a Strategic Asset Allocation Index of 99.4% as of June 2023. Strategic assets (PP&E of CN¥1.51 Billion plus long-term investments of CN¥-) total CN¥1.51 Billion, measured against net assets of CN¥1.52 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Nanjing Well Pharmaceutical Co Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Nanjing Well Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 99.4%, representing strategic assets of CN¥1.51 Billion against net assets of CN¥1.52 Billion CNY. Explore cash efficiency ratio of Nanjing Well Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Nanjing Well Pharmaceutical Co Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Nanjing Well Pharmaceutical Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Nanjing Well Pharmaceutical Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 100.0% | CN¥1.48 Billion | CN¥1.48 Billion | CN¥- | CN¥1.48 Billion | ▲ +12.5 pp |
| 2021 | 87.5% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥1.39 Billion | ▲ +15.1 pp |
| 2020 | 72.4% | CN¥940.80 Million | CN¥940.80 Million | CN¥- | CN¥1.30 Billion | ▲ +32.1 pp |
| 2019 | 40.3% | CN¥500.65 Million | CN¥500.65 Million | CN¥- | CN¥1.24 Billion | ▼ -19.8 pp |
| 2018 | 60.1% | CN¥369.32 Million | CN¥369.32 Million | CN¥- | CN¥614.61 Million | ▲ +2.8 pp |
| 2017 | 57.3% | CN¥305.30 Million | CN¥305.30 Million | CN¥- | CN¥532.80 Million | ▲ +4.4 pp |
| 2016 | 52.9% | CN¥234.80 Million | CN¥234.80 Million | CN¥- | CN¥443.99 Million | — |